Literature DB >> 10720595

Angiotensinogen concentrations and renin clearance : implications for blood pressure regulation.

J Bohlender1, J Ménard, D Ganten, F C Luft.   

Abstract

Renin (REN) requires seconds to convert angiotensinogen (AGT) to angiotensin I. We tested the hypothesis that this long catalytic cycle might indicate an influence of AGT concentrations on REN clearance. We studied 2 transgenic rat (TGR) strains for human (h) AGT; one strain has hAGT values approximately 7-fold higher than the other (68+/-18 versus 10+/-4 microg angiotensin I/mL). hREN (30 000 pg) was bolus-infused into both lines and into nontransgenic controls. The terminal half-life (T1/2beta) was increased (130 versus 82 minutes) and the metabolic clearance rate (MCR) was decreased (0.83+/-0.29 versus 2.2+/-0.66 microL. min(-1). g(-1)) in the high hAGT strain compared with the low hAGT strain. The difference was not related to volume of distribution at steady state. Infused hREN blocked with remikiren resulted in T1/2beta and MCR values that were not different from control values. Infused unblocked and blocked radiolabeled hREN was distributed similarly in the hAGT TGR strains. Infused mouse REN, which cannot convert hAGT, had similar T1/2beta and MCR values in hAGT TGR. Measuring REN with direct radioimmunoassay or by enzyme kinetic assay gave similar results. We next crossed homozygous hAGT TGR from both strains with homozygous hREN TGR. Heterozygous offspring from the low hAGT TGR strain had plasma REN activity, hREN concentration, and rat AGT values that were no different from those of their parents. However, TGR offspring with high hAGT values had massively elevated plasma REN activity and hREN concentration as well as elevated blood pressure, even though both the hREN and rREN genes are downregulated. We conclude that increased AGT concentrations decrease REN MCR and increase REN T1/2beta. The REN-AGT complex may stabilize plasma REN concentration and regulate plasma REN activity independent of renal REN secretion and angiotensin II-mediated feedback. These effects could augment angiotensin I generation and influence blood pressure. The notion that AGT is merely a passive substrate reservoir for REN should be revised.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10720595     DOI: 10.1161/01.hyp.35.3.780

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  20 in total

1.  Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension.

Authors:  H Kobori; L M Harrison-Bernard; L G Navar
Journal:  Hypertension       Date:  2001-05       Impact factor: 10.190

Review 2.  Intratubular renin-angiotensin system in hypertension.

Authors:  L Gabriel Navar; Hiroyuki Kobori; Minolfa C Prieto; Romer A Gonzalez-Villalobos
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

3.  Contribution of a nuclear factor-kappaB binding site to human angiotensinogen promoter activity in renal proximal tubular cells.

Authors:  Omar W Acres; Ryousuke Satou; L Gabriel Navar; Hiroyuki Kobori
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

4.  Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseases.

Authors:  Hiroyuki Kobori; Yuri Ozawa; Yuki Suzaki; Minolfa C Prieto-Carrasquero; Akira Nishiyama; Tatsuya Shoji; Eric P Cohen; L Gabriel Navar
Journal:  Am J Hypertens       Date:  2006-05       Impact factor: 2.689

5.  Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease.

Authors:  Maki Urushihara; Hiroyuki Kobori
Journal:  Int J Clin Med       Date:  2011-09-01

6.  Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients.

Authors:  Hiroyuki Kobori; A Brent Alper; Rajesh Shenava; Akemi Katsurada; Toshie Saito; Naro Ohashi; Maki Urushihara; Kayoko Miyata; Ryousuke Satou; L Lee Hamm; L Gabriel Navar
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

7.  Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA.

Authors:  Hiroyuki Kobori; Akemi Katsurada; Kayoko Miyata; Naro Ohashi; Ryousuke Satou; Toshie Saito; Yoshiaki Hagiwara; Kazuya Miyashita; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2008-03-19

8.  Real-time electrochemical detection of ATP and H₂O₂ release in freshly isolated kidneys.

Authors:  Oleg Palygin; Vladislav Levchenko; Daria V Ilatovskaya; Tengis S Pavlov; Robert P Ryan; Allen W Cowley; Alexander Staruschenko
Journal:  Am J Physiol Renal Physiol       Date:  2013-04-17

Review 9.  Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease.

Authors:  Hiroyuki Kobori; Maki Urushihara
Journal:  Pflugers Arch       Date:  2012-08-24       Impact factor: 3.657

10.  Angiotensin II type 1 receptor 1166C polymorphism is associated with abdominal aortic aneurysm in three independent cohorts.

Authors:  Gregory T Jones; Andrew R Thompson; Frank M van Bockxmeer; Hany Hafez; Jackie A Cooper; Jonathan Golledge; Stephen E Humphries; Paul E Norman; Andre M van Rij
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-31       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.